India's Decade of Collaboration
Harvard Business Review
MAY 31, 2011
Biocon also sources drug molecules from other partners, especially from developing countries, such as the Cuba-based Center of Molecular Immunology (CMI). Biocon's core competency lies in building and orchestrating global innovation networks — the cornerstone of a polycentric innovation model.
13 
Let's personalize your content